Moran Michael Shawn

EVP, Chief Commercial Officer

Eagle Pharmaceuticals, Inc.

US, Woodcliff Lake [HQ]

CIK 1886788

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

22,667

Price per Share :

$0.62

Equivalence :

$14,053.54

F

Form 4

22,667 Shares After Transaction

Value : $1,147,630.21

$4,556.70

Transaction Date : 01/07/22
- Footnotes
- Form 4
Footnotes:
#1 Represents shares withheld to satisfy withholding tax obligations.
F

Form 4

22,457 Shares After Transaction

Value : $1,031,674.58

$9,647.40

Transaction Date : 01/31/22
- Footnotes
- Form 4
Footnotes:
#1 Represents shares withheld to satisfy withholding tax obligations.
F

Form 4

22,757 Shares After Transaction

Value : $1,153,552.33

$76,592.59

Transaction Date : 01/05/22
- Footnotes
- Form 4
Footnotes:
#1 Represents shares withheld to satisfy withholding tax obligations.
A

Form 4

32,115 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 02/28/22
- Footnotes
- Form 4
Footnotes:
#1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
F

Form 4

21,715 Shares After Transaction

Value : $977,826.45

$33,412.26

Transaction Date : 02/02/22
- Footnotes
- Form 4
Footnotes:
#1 Represents shares withheld to satisfy withholding tax obligations.